{{Rsnum
|rsid=4041245
|Gene=MBD2
|Chromosome=18
|position=54159155
|Orientation=plus
|GMAF=0.427
|Gene_s=MBD2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 45.1 | 32.7
| HCB | 25.5 | 38.7 | 35.8
| JPT | 18.6 | 38.9 | 42.5
| YRI | 36.7 | 47.6 | 15.6
| ASW | 29.8 | 49.1 | 21.1
| CHB | 25.5 | 38.7 | 35.8
| CHD | 18.3 | 35.8 | 45.9
| GIH | 10.9 | 31.7 | 57.4
| LWK | 21.8 | 54.5 | 23.6
| MEX | 12.1 | 25.9 | 62.1
| MKK | 16.7 | 46.8 | 36.5
| TSI | 21.6 | 46.1 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22258532
|Title=A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
|OA=1
}}

{{on chip | Affy GenomeWide 6}}